Hi-Tech Pharma to Release Purified NMN+ NR Product

Hi-Tech Pharmaceuticals, Inc., based in Norcross, Georgia, has announced plans to release a highly purified NMN+NR product following a successful pilot launch. β-Nicotinamide mononucleotide (NMN), a derivative of the B-vitamin niacin, is known for its potential to significantly enhance health and wellness. NMN, a natural compound present in the human body and certain foods, serves as a precursor to NAD+, a crucial coenzyme involved in energy production, metabolism, and gene expression.

Similarly, Nicotinamide Riboside (NR) is a naturally occurring molecule found in all cells and acts as a building block for NAD⁺ production. NR is intended to boost NAD⁺ levels, thereby sustaining cellular function and promoting vitality and longevity.

Hi-Tech Pharmaceuticals' NMN+NR product aims to employ a multi-target strategy for NAD⁺ restoration. By using precursors alongside inhibitors and activators within the NAD⁺ network, the company believes it can more effectively restore NAD⁺ levels. This combination is intended to support various vital processes such as energy production, DNA repair, gene regulation, cellular health, immune function, and the sleep-wake cycle.

Given that NAD+ levels naturally decrease with age, supplements like NMN+NR can help replenish these levels. Potential benefits of such supplementation include slowing the aging process, improving cardiovascular function, supporting wellness, aiding in healthy weight management, and enhancing endurance.

One challenge with standard NMN and NR supplements is their limited absorption due to extensive metabolism and low stability. To overcome this, Hi-Tech Pharmaceuticals uses an advanced delivery system known as Cyclosome®, which combines liposomal and cyclodextrin technologies. This system is designed to improve bioavailability, resulting in better absorption and slower release into the bloodstream.

Jared Wheat, CEO of Hi-Tech Pharmaceuticals, expressed enthusiasm about the upcoming launch of the highly purified NMN+NR product. He emphasized the company's proven track record in providing superior ingredients, ensuring that customers receive high-quality, pure supplements. Wheat sees NMN+NR as a natural addition to Hi-Tech's comprehensive healthcare category, considering it an ideal non-medicine therapy. The new product is expected to become a significant star in Hi-Tech's portfolio, which already includes numerous products utilizing their proprietary Cyclosome® delivery system. This addition is poised to offer revenue stability, increased visibility, and a robust product pipeline to support the company's ongoing growth.

Hi-Tech Pharmaceuticals has seen substantial success in the market, creating, manufacturing, and selling high-quality products. The company's growth strategy has focused on mergers and acquisitions, allowing it to expand its market share in the United States significantly. Notable acquisitions include Synergy Nutritional Industries in 2005 and Nittany Pharmaceuticals in 2012. Hi-Tech has also acquired major brands such as APS Nutrition, ALR, FormuTech Nutrition, Sports One, Innovative Laboratories, LG Sciences, iForce Nutrition, Prime Nutrition, Top Secret Nutrition, and EAS. The company's healthcare products are based on its proprietary Cyclosome® Technology. According to its leaders, Hi-Tech plans to continue its growth through further merger and acquisition activities.